IGC Pharma, Inc. (IGC)
0.3063
0.00 (0.00%)
USD |
NYAM |
Aug 26, 16:00
0.3063
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Shareholders Equity (Quarterly) : 6.132M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.132M |
| March 31, 2026 | 6.121M |
| December 31, 2025 | 7.423M |
| September 30, 2025 | 8.092M |
| June 30, 2025 | 6.078M |
| March 31, 2025 | 6.33M |
| December 31, 2024 | |
| September 30, 2024 | 7.377M |
| June 30, 2024 | 7.88M |
| March 31, 2024 | 7.321M |
| December 31, 2023 | 9.053M |
| September 30, 2023 | 14.10M |
| June 30, 2023 | 13.20M |
| March 31, 2023 | 14.91M |
| December 31, 2022 | 18.32M |
| September 30, 2022 | 20.14M |
| June 30, 2022 | 22.04M |
| March 31, 2022 | 23.89M |
| December 31, 2021 | 29.48M |
| September 30, 2021 | 31.26M |
| June 30, 2021 | 31.74M |
| March 31, 2021 | 32.80M |
| December 31, 2020 | 21.47M |
| September 30, 2020 | 23.60M |
| June 30, 2020 | 24.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.54M |
| December 31, 2019 | 29.79M |
| September 30, 2019 | 31.24M |
| June 30, 2019 | 32.42M |
| March 31, 2019 | 33.57M |
| December 31, 2018 | 36.56M |
| September 30, 2018 | 13.81M |
| June 30, 2018 | 7.577M |
| March 31, 2018 | 8.065M |
| December 31, 2017 | 7.484M |
| September 30, 2017 | 6.230M |
| June 30, 2017 | 6.104M |
| March 31, 2017 | 7.359M |
| December 31, 2016 | 7.549M |
| September 30, 2016 | 14.40M |
| June 30, 2016 | 13.10M |
| March 31, 2016 | 13.48M |
| December 31, 2015 | 13.09M |
| September 30, 2015 | 13.57M |
| June 30, 2015 | 13.98M |
| March 31, 2015 | 14.23M |
| December 31, 2014 | 15.74M |
| September 30, 2014 | 15.36M |
| June 30, 2014 | 16.25M |
| March 31, 2014 | 13.63M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 1.044M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 562.20M |
| Fulcrum Therapeutics, Inc. | 310.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.496M |
| Total Liabilities (Quarterly) | 3.364M |
| Debt to Equity Ratio | 0.1765 |
| Current Ratio | 0.3932 |
| Net Debt Paydown Yield | -0.60% |